These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30239757)

  • 1. Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.
    Braun LR; Feldpausch MN; Czerwonka N; Weiss J; Branch K; Lee H; Martinez-Salazar EL; Torriani M; Sponseller CA; Grinspoon SK; Stanley TL
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4176-4186. PubMed ID: 30239757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.
    Park JB; Jung JH; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Sohn DW
    Trials; 2017 Oct; 18(1):501. PubMed ID: 29078817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
    Latva-Rasku A; Honka MJ; Kullberg J; Mononen N; Lehtimäki T; Saltevo J; Kirjavainen AK; Saunavaara V; Iozzo P; Johansson L; Oscarsson J; Hannukainen JC; Nuutila P
    Diabetes Care; 2019 May; 42(5):931-937. PubMed ID: 30885955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver fat content and hepatic insulin sensitivity in overweight patients with type 1 diabetes.
    Llauradó G; Sevastianova K; Sädevirta S; Hakkarainen A; Lundbom N; Orho-Melander M; Groop PH; Forsblom C; Yki-Järvinen H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):607-16. PubMed ID: 25405502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
    Simon TG; Wilechansky RM; Stoyanova S; Grossman A; Dichtel LE; Lauer GM; Miller KK; Hoshida Y; Corey KE; Loomba R; Chung RT; Chan AT
    JAMA; 2024 Mar; 331(11):920-929. PubMed ID: 38502074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
    Syvertsen C; Halse J; Høivik HO; Gaullier JM; Nurminiemi M; Kristiansen K; Einerhand A; O'Shea M; Gudmundsen O
    Int J Obes (Lond); 2007 Jul; 31(7):1148-54. PubMed ID: 17031391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of pitavastatin on glucose metabolism in patients with type 2 diabetes with hypercholesterolemia.
    Daido H; Horikawa Y; Takeda J
    Diabetes Res Clin Pract; 2014 Dec; 106(3):531-7. PubMed ID: 25458331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients.
    Szendroedi J; Anderwald C; Krssak M; Bayerle-Eder M; Esterbauer H; Pfeiler G; Brehm A; Nowotny P; Hofer A; Waldhäusl W; Roden M
    Diabetes Care; 2009 Feb; 32(2):209-14. PubMed ID: 18957532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
    Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
    Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a whole diet approach on metabolic flexibility, insulin sensitivity and postprandial glucose responses in overweight and obese adults - A randomized controlled trial.
    Fechner E; Bilet L; Peters HPF; Hiemstra H; Jacobs DM; Op 't Eyndt C; Kornips E; Mensink RP; Schrauwen P
    Clin Nutr; 2020 Sep; 39(9):2734-2742. PubMed ID: 31899037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Kurogi K; Michishita I; Nozue T; Sugiyama S; Tsimikas S; Yoshida H; Ray KK
    Atherosclerosis; 2015 Aug; 241(2):409-18. PubMed ID: 26074315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial.
    Most J; Timmers S; Warnke I; Jocken JW; van Boekschoten M; de Groot P; Bendik I; Schrauwen P; Goossens GH; Blaak EE
    Am J Clin Nutr; 2016 Jul; 104(1):215-27. PubMed ID: 27194304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Exercise Modality on Insulin Resistance and Ectopic Fat in Adolescents with Overweight and Obesity: A Randomized Clinical Trial.
    Lee S; Libman I; Hughan K; Kuk JL; Jeong JH; Zhang D; Arslanian S
    J Pediatr; 2019 Mar; 206():91-98.e1. PubMed ID: 30554789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies.
    Chapman MJ; Orsoni A; Robillard P; Hounslow N; Sponseller CA; Giral P
    Curr Med Res Opin; 2014 May; 30(5):775-84. PubMed ID: 24328357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nadolol reduces insulin sensitivity in liver cirrhosis: a randomized double-blind crossover trial.
    Lee WG; Murphy R; McCall JL; Gane EJ; Soop M; Tura A; Plank LD
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27667324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS).
    Zhang J; Shao Y; Liu Y; Tao J
    Cardiovasc Drugs Ther; 2018 Dec; 32(6):581-589. PubMed ID: 30187345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans.
    van der Crabben SN; Blümer RM; Stegenga ME; Ackermans MT; Endert E; Tanck MW; Serlie MJ; van der Poll T; Sauerwein HP
    J Clin Endocrinol Metab; 2009 Feb; 94(2):463-8. PubMed ID: 18984669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency.
    Yuen KC; Roberts CT; Frystyk J; Rooney WD; Pollaro JR; Klopfenstein BJ; Purnell JQ
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1862-9. PubMed ID: 25013996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up.
    Jeong HS; Hong SJ; Son S; An H; Kook H; Joo HJ; Park JH; Yu CW; Lim DS
    Cardiovasc Diabetol; 2019 Nov; 18(1):162. PubMed ID: 31752850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.